Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Compounding Pharmacies Market

Compounding Pharmacies Market Share

Report ID: GMI749
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Compounding Pharmacies Market Share

The competitive landscape in the compounding pharmacies industry is characterized by a mix of large-scale, well-established players and smaller, independent pharmacies. Major companies such as B. Braun Melsungen AG and Fagron NV are prominent due to their extensive product offerings, advanced compounding technologies, and strong distribution networks. These key players invest heavily in research and development to innovate and comply with stringent regulatory standards, ensuring high-quality, customized medications. Smaller compounding pharmacies, while fewer in resources, compete by offering personalized services and niche products tailored to specific patient needs. The market is further intensified by strategic mergers, acquisitions, and partnerships aimed at expanding geographic reach and enhancing technological capabilities.

Compounding Pharmacies Market Companies

Prominent players operating in the compounding pharmacies industry include:

B. Braun Melsungen AG
Clinigen Group PLC
Dougherty's Pharmacy, Inc.
Fagron NV
Fresenius Kabi AG
ITC Compounding Pharmacy
Institutional Pharmacy Solutions, LLC
Lorraine’s Pharmacy
McGuff Compounding Pharmacy Services
Nephron Pharmaceuticals Corporation
Pencol Compounding Pharmacy
Rx3 Compounding Pharmacy
Triangle Compounding Pharmacies
Valor Compounding Pharmacy, Inc.
Wedgewood Village Pharmacy, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Compounding pharmacies market was valued at USD 12.4 billion in 2023 and is anticipated to witness growth at 5.6% CAGR through 2032 driven by the increasing demand for personalized medications.

The pain management segment in the market held 33.3% share in 2023 owing to growing incidence of chronic pain among adults and rising geriatric population.

North America compounding pharmacies market was valued at USD 6.8 billion in 2023 and is anticipated to reach USD 11 billion by 2032 as participants are focusing on the development of compounded medications to better manage patients.

B. Braun Melsungen AG, Clinigen Group PLC, Dougherty's Pharmacy, Inc., Fagron NV, Fresenius Kabi AG, ITC Compounding Pharmacy, Institutional Pharmacy Solutions, LLC, Lorraine’s Pharmacy, McGuff Compounding Pharmacy Services, and Nephron Pharmaceuticals Corporation, among others.